Consultor le portail de référence du conseil en stratégie Consultor le portail de référence du conseil en stratégie

News, elucidation and outlooks
on strategy consulting

Belgian biopharmaceutical company, Ablynx, has named former BCG advisor, Markus L.E. Ewert, as its newest Chief Business Officer (CBO). Ewert, who has also worked at Novartis in its Cardiovascular and Metabolism franchise and Molecular Diagnostics unit as head of strategy, global BD&L, and M&A, was formerly at Boston Consulting Group between 1993-1995 as an advisor to pharmaceutical and chemical companies. He holds a doctorate in molecular biology & pharmacy from Heidelberg Univeristy.

markus ewert

See : https://european-biotechnology.com

Peter Crush for Consultor.news

Consultor uses Cookies, to offer you the best service possible. If you continue using the website, you agree with our use of cookies.